SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000905148-12-000358
Filing Date
2012-02-13
Accepted
2012-02-13 12:32:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 efc12-46_fmsc13ga.htm SC 13G/A 155721
  Complete submission text file 0000905148-12-000358.txt   157165
Mailing Address 135 EAST 57, 30 TH FLOOR NEW YORK NY 10022
Business Address 135 EAST 57, 30 TH FLOOR NEW YORK NY 10022 212-317-7520
Invus Public Equities, LP (Filed by) CIK: 0001340097 (see all company filings)

IRS No.: 980420215
Type: SC 13G/A

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Subject) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82196 | Film No.: 12597014
SIC: 2834 Pharmaceutical Preparations